Either one should work, I think it depends on what you're able to get. Domperidone is banned in some places. They have different potential side effects as well.
Either one should work, I think it depends on what you're able to get. Domperidone is banned in some places. They have different potential side effects as well.
Sounds like it's a perfect candidate for the job then . Jokes aside, that seems to be a risk only of one has been using it for a while. The thing that's scary about meto is stuff like dystonia or akathesia.. and other similar extrapyramidal symptoms..
Sounds like it's a perfect candidate for the job then . Jokes aside, that seems to be a risk only of one has been using it for a while. The thing that's scary about meto is stuff like dystonia or akathesia.. and other similar extrapyramidal symptoms..
I think taking Olanzapine and 48 hour regime of domperidone might be a good alternative. But I just feel like going with meto as of now as it is mentioned as part of the protocol in pph and feel like maybe sticking to it might give me a better chance. I wonder if these effects could manifest on taking the Stat dose that too like 40 mins to an hour within taking it?
I think taking Olanzapine and 48 hour regime of domperidone might be a good alternative. But I just feel like going with meto as of now as it is mentioned as part of the protocol in pph and feel like maybe sticking to it might give me a better chance. I wonder if these effects could manifest on taking the Stat dose that too like 40 mins to an hour within taking it?
I wonder if I should test the meto beforehand or if I should take it directly before ctb. I understand taking it only makes one more prone to the symptoms.. Not sure what to do here..
This is a website that has discussions of explicit content that isn't for anyone under the age of 18. If you're under the age of 18, you must discontinue using this site.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.